Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Buprenorfina")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1070

  • Page / 43
Export

Selection :

  • and

Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically ActiveBROWN, Sarah M; HOLTZMAN, Michael; KIM, Thomas et al.Anesthesiology (Philadelphia). 2011, Vol 115, Num 6, pp 1251-1260, issn 0003-3022, 10 p.Article

BuprenorphineFOSTER, Bethany; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2013, Vol 45, Num 5, pp 939-949, issn 0885-3924, 11 p.Article

Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effectLIU, Kuo-Sheng; TZENG, Jann-Inn; CHEN, Yu-Wen et al.Anesthesia and analgesia. 2006, Vol 102, Num 5, pp 1445-1451, issn 0003-2999, 7 p.Article

Buprenorphine use : The international experiencePATRIZIA CARRIERI, Maria; AMASS, Leslie; LUCAS, Gregory M et al.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S197-S215, SUP4Conference Paper

Transdermal buprenorphine for treating nociceptive and neuropathic pain : Four case studiesLIKAR, Rudolf; SITTL, Reinhard.Anesthesia and analgesia. 2005, Vol 100, Num 3, pp 781-785, issn 0003-2999, 5 p.Article

Buprénorphine:faut-il sevrer?PORCHER, Marion; POUTRAIN, Jean-Christophe; LAPEYRE-MESTRE, Maryse et al.La Revue du praticien. Médecine générale. 2012, Num 876, pp 166-167, issn 0989-2737, 2 p.Article

Reflexions pratiques sur les médicaments détournés de leur usage = Practical reflections on the misuse of drugsBOULEY, M; VIRIOT, E; BARACHE, D et al.Thérapie (Paris). 2000, Vol 55, Num 2, pp 295-301, issn 0040-5957Article

Livedoid and Necrotic Skin Lesions Due to Intra-arterial Buprenorphine Injections Evidenced by Maltese CrossI-Shaped Histologic BodiesSCHNEIDER, Pierre; DUONG, Tu-Anh; ORTONNE, Nicolas et al.Archives of dermatology (1960). 2010, Vol 146, Num 2, pp 208-209, issn 0003-987X, 2 p.Article

In vitro metabolism study of buprenorphine : Evidence for new metabolic pathwaysPICARD, Nicolas; CRESTEIL, Thierry; DJEBLI, Nassim et al.Drug metabolism and disposition. 2005, Vol 33, Num 5, pp 689-695, issn 0090-9556, 7 p.Article

The novel depot of buprenorphine propionate has a long-acting effect on physical dependence on morphineLIU, Kuo-Sheng; LIN, Ching-Nan; SHIEH, Ja-Ping et al.Drug development research. 2006, Vol 67, Num 5, pp 462-469, issn 0272-4391, 8 p.Article

Politique d'observation des pratiques cliniques liées a l'utilisation de la buprénorphinePARQUET, Philippe-Jean.THS la revue des addictions. 2006, Vol 8, Num 29, pp 1453-1454, issn 1624-0898, 2 p.Article

Local Anesthetic-like Inhibition of Voltage-gated Na+ Channels by the Partial μ-opioid Receptor Agonist BuprenorphineLEFFLER, Andreas; FRANK, Georg; KISTNER, Katrin et al.Anesthesiology (Philadelphia). 2012, Vol 116, Num 6, pp 1335-1346, issn 0003-3022, 12 p.Article

Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugsNORDBØ, A; SKURTVEIT, S; BORCHGREVINK, P. C et al.Acta anaesthesiologica scandinavica. 2012, Vol 56, Num 1, pp 88-94, issn 0001-5172, 7 p.Article

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteersYASSEN, Ashraf; OLOFSEN, Erik; ROMBERG, Raymonda et al.Anesthesiology (Philadelphia). 2006, Vol 104, Num 6, pp 1232-1242, issn 0003-3022, 11 p.Article

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxificationSOBEL, Bai-Fang X; SIGMON, Stacey C; WALSH, Sharon L et al.Drug and alcohol dependence. 2004, Vol 73, Num 1, pp 11-22, issn 0376-8716, 12 p.Article

Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerationsTZSCHENTKE, Thomas M.Psychopharmacologia. 2004, Vol 172, Num 1, pp 58-67, issn 0033-3158, 10 p.Article

Intoxications par opiacés/opioïdes depuis l'avènement de la buprénorphine haut dosage = Opiate/opioid poisonings since the advent of high dosage buprenorphineGUEYE, Papa; PIRNAY, Stéphane; MEGARBANE, Bruno et al.Alcoologie et addictologie. 2004, Vol 26, Num 3, pp 235-242, issn 1620-4522, 8 p.Article

Buprenorphine in pregnant opioid-dependent women: first results of a prospective studyLACROIX, I; BERREBI, A; CHAUMERLIAC, C et al.Addiction (Abingdon. Print). 2004, Vol 99, Num 2, pp 209-214, issn 0965-2140, 6 p.Article

Serious overdoses involving buprenorphine in HelsinkiBOYD, T; RANDELL, T; LUURILA, H et al.Acta anaesthesiologica scandinavica. 2003, Vol 47, Num 8, pp 1031-1033, issn 0001-5172, 3 p.Article

The Pharmacokinetic and Pharmacodynamic Interactions Between Buprenorphine/Naloxone and Elvitegravir/ Cobicistat in Subjects Receiving Chronic Buprenorphine/ Naloxone TreatmentBRUCE, Robert Douglas; WINKLE, Peter; CUSTODIO, Joseph M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 4, pp 480-484, issn 1525-4135, 5 p.Article

THE OPIATE ANALGESIC BUPRENORPHINE DECREASES PROLIFERATION OF ADULT HIPPOCAMPAL NEUROBLASTS AND INCREASES SURVIVAL OF THEIR PROGENYPETTIT, A. S; DESROCHES, R; BENNETT, S. A. L et al.Neuroscience. 2012, Vol 200, pp 211-222, issn 0306-4522, 12 p.Article

Pharmacokinetic-Pharmacodynamic Relationships of Cognitive and Psychomotor Effects of Intravenous Buprenorphine Infusion in Human VolunteersJENSEN, Mette L; SJØGREN, Per; UPTON, Richard N et al.Basic & clinical pharmacology & toxicology (Print). 2008, Vol 103, Num 1, pp 94-101, issn 1742-7835, 8 p.Article

Cognitive Functioning During Methadone and Buprenorphine Treatment : Results of a Randomized Clinical TrialSOYKA, Michael; LIEB, Martin; KAGERER, Sabine et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 6, pp 699-703, issn 0271-0749, 5 p.Article

Impact des traitements de substitution par BHD chez les détenus pharmacodépendants aux opiacés = Impact of buprenorphin replacement therapies in opiates dependant prisonersCALINIER, Anne; CAER, Yves; ESCAFFRE, Noëlle et al.THS la revue des addictions. 2004, Vol 6, Num 21, pp 1086-1088, issn 1624-0898, 3 p.Article

Evaluation of an injection- depot formulation of buprenorphine: placebo comparisonSIGMON, Stacey C; WONG, Conrad J; CHAUSMER, Allison L et al.Addiction (Abingdon. Print). 2004, Vol 99, Num 11, pp 1439-1449, issn 0965-2140, 11 p.Article

  • Page / 43